Farmaceutica R (RMAH) — Net Asset Quality Index
Farmaceutica R (RMAH) has a Net Asset Quality Index of 21.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RON345.32 Million minus total liabilities of RON271.82 Million yields net assets of RON73.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read RMAH total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Farmaceutica R Net Asset Quality Index Over Time (2020–2025)
This chart shows how Farmaceutica R's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the index stands at 21.3%, representing net assets of RON73.50 Million against total assets of RON345.32 Million RON. See Farmaceutica R (RMAH) shareholders funds for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Farmaceutica R (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Farmaceutica R market cap and net worth.
| Year | Quality Index | Net Assets (RON) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 20.8% | RON79.61 Million | RON383.19 Million | RON303.58 Million | ▲ +1.1 pp |
| 2024 | 19.7% | RON73.94 Million | RON375.04 Million | RON301.09 Million | ▼ -2.7 pp |
| 2023 | 22.4% | RON70.86 Million | RON315.76 Million | RON244.90 Million | ▼ -1.5 pp |
| 2022 | 23.9% | RON68.43 Million | RON286.20 Million | RON217.77 Million | ▼ -3.3 pp |
| 2021 | 27.2% | RON68.22 Million | RON251.07 Million | RON182.85 Million | ▼ -5.5 pp |
| 2020 | 32.7% | RON79.83 Million | RON244.46 Million | RON164.63 Million | — |